Ensuring Stability Excellence for Global Consumer and OTC Products

Ascertaining drug stability is an essential step of the product development process and must be performed in accordance with strict regulatory requirements. In this webinar, Recipharm present the guidance provided by the ICH to help support companies in maintaining a rigorous approach to stability testing, and detail what it takes to meet its requirements.

Register Free: https://www.pharmtech.com/pt/otc-products

Event Overview:

Stability testing is an essential step in the product development process and a mandatory requirement in the life cycle of a treatment. The International Council on Harmonisation - Quality (ICH Q1A) guidance exists to support companies in maintaining a rigorous approach to stability testing. This webinar will explore the detail of ICH Q1A and explain how to meet its requirements.

Key Learning Objectives

• Understand the different stability requirements for each drug product type
• Learn about the critical stability requirements for your consumer healthcare products
• Understand the key benefits of working with an expert stability study partner
• Understand what needs to be considered to run a major stability program successfully

Who Should Attend
Formulation Scientist, Production Manager, Senior Vice President Production, Director of Production Operations, Director of Manufacturing, Vice President of Global Supply Chain, Head of Supply Chain Management, Senior Vice President Supply Chain, Supply Manager, Vice President Project, Director of Procurement, Development Manager, Head of Production, Formulation Chemist, Vice President Global Procurement, Director of Development, Project Director, Vice President of Production, Vice President of Manufacturing, Chief Operating Officer, Head of Procurement, Vice President Supply Chain, Project Manager, Head of Product Development, Senior Project Director, Senior Category Manager, Supply Chain Manager, Category Manager, Supply Director, Vice President Procurement, Category Development Manager, Director of Project Development, Category Director, Procurement Manager, Production Director, Manufacturing Manager, Senior Project Manager, Vice President of Development, Chief Executive Officer, Chief Scientific Officer, Head of Manufacturing, Director Project Operations, Head of Development, Mid-sized and big pharma companies, Phase 3 and commercial phase buyers

Speaker

Ramesh Jagadeesan
Asst. Vice President, Analytical Development
Recipharm

Ramesh Jagadeesan has a Ph.D. in Pharmaceutical Analysis and is currently heading the Analytical Centre of Excellence at Recipharm, Bengaluru, India. He has 22 years of experience in analytical research and development. He has authored numerous research publications in the areas of analytical development, analytical validation, controlled release technology and stability studies. He is an expert in stability studies for NCE, ANDA, commercial and clinical stability.

Register Free: https://www.pharmtech.com/pt/otc-products